Stock screenerAll disclosures → EDGAR →
BIAFW
Conviction 62IndustrialsScan · Tue, Sep 8, 2026BIAFW$0.5970-14.71%
ResistanceSupportVol 14Vol MA14 15.66K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
bioAffinity Technologies, Inc.SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHwww.bioaffinitytech.com ↗
Price0.5970
Change-14.71%
Gap-5.71%
Rel volume0.15×
Avg volume11.44K
Avg $ vol3.62K
SMA 200.1362
SMA 500.0817
SMA 2000.1207
Price vs 50+631.08%
Price vs 200+394.70%
MA stackmixed
50/200 cross—
Supertrendup · 0.2464
RSI (14)73
MACD hist0.07
MACD crossbull · 4d
Stoch %K / %D76 / 78
ADX (14)24
+DI / −DI63 / 9
RSI divergence—
MACD divergence—
ATR %+18.10%
ADR %44.06%
52w high0.7000
52w low0.0000
From 52w high-14.71%
Above 52w low—
New 52w highNo
SqueezeOff
Bollinger width575.03%
%B1.09
Donchian pos75.57%
Donchian high0.7900
Donchian low0.0000
AVWAP (52w high)0.3230
vs AVWAP high+84.85%
AVWAP (52w low)0.3294
vs AVWAP low+81.26%
OBV trendUp
Chaikin MF (20)-0.18
Today vs 20d0.15×
Avg vol (14d)15.66K
Avg vol (20d)11.44K
Avg $ vol (20d)3.62K
Market cap4.84M
RS 3m (vs SPY)+245.75%
RS 6m (vs SPY)—
RS line new highYes
Trend template6/8
Technical rank98.4
1 week—
1 month—
3 months+281.23%
6 months+170.99%
1 year—
YTD—
P/E-0.32
P/B1.28
P/S0.78
P/FCF-0.52
EPS-8.66
Div yield—
ROE-395.61%
ROA-195.68%
Debt/Eq0.03
Current1.44
EV/EBITDA—
Gross margin0.07%
Net margin-241.96%
Rev growth-34.18%
EPS growth-64.93%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value2.53M
Revenue1.51M
Net income-3.37M
Gross profit223.78K
Free cash flow-9.39M
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out1.6M
Employees57
ListedWed, Aug 10, 2022
Free float8.1M
Float %100.0%
Short interest4.07K
Days to cover5.7d
Short volume5.1%
Squeeze score25 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction62 / 100
Pattern quality—
Tech rank98.4 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.1325
Support0.0000
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right?Yahoo Finance · Sat, Sep 5, 2026
Congress activity
Disclosed STOCK Act trades in BIAFW
No recent disclosed trades by Congress in BIAFW. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BIAFW
No recent insider (Form 4) filings in BIAFW. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in BIAFW
No recent SEC filings on file for BIAFW.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.